Abstract:The glucose transporter family (GLUT) consists of fourteen members. It is responsible for glucose homeostasis and glucose transport from the extracellular space to the cell cytoplasm to further cascade catalysis. GLUT proteins are encoded by the solute carrier family 2 (SLC2) genes and are members of the major facilitator superfamily of membrane transporters. Moreover, different GLUTs also have their transporter kinetics and distribution, so each GLUT member has its uniqueness and importance to play essential roles in human physiology. Evidence from many studies in the field of diabetes showed that GLUT4 travels between the plasma membrane and intracellular vesicles (GLUT4-storage vesicles, GSVs) and that the PI3K/Akt pathway regulates this activity in an insulin-dependent manner or by the AMPK pathway in response to muscle contraction. Moreover, some published results also pointed out that GLUT4 mediates insulin-dependent glucose uptake. Thus, dysfunction of GLUT4 can induce insulin resistance, metabolic reprogramming in diverse chronic diseases, inflammation, and cancer. In addition to the relationship between GLUT4 and insulin response, recent studies also referred to the potential upstream transcription factors that can bind to the promoter region of GLUT4 to regulating downstream signals. Combined all of the evidence, we conclude that GLUT4 has shown valuable unknown functions and is of clinical significance in cancers, which deserves our in-depth discussion and design compounds by structure basis to achieve therapeutic effects. Thus, we intend to write up a most updated review manuscript to include the most recent and critical research findings elucidating how and why GLUT4 plays an essential role in carcinogenesis, which may have broad interests and impacts on this field.

Facilitative glucose transporters:expression,distribution and the relationship to diseases

Molecular Insights into the Glucose Transporter GLUT5

The Vesicle Traffic and Related Clinical Diseases of Glucose Transporter 4

GLUT5: structure, functions, diseases and potential applications.

Glucose Transporter 1, Distribution in the Brain and in Neural Disorders: Its Relationship with Transport of Neuroactive Drugs Through the Blood-Brain Barrier

Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease

Relationship of Glucose Transporter 1 and Malignant Tumor: an Advance

Intestinal Epithelium Major Glucose Transporters and Their Action Mechanisms

Glucose transporter 4: Insulin response mastermind, glycolysis catalyst and treatment direction for cancer progression

GLUT, SGLT, and SWEET: Structural and Mechanistic Investigations of the Glucose Transporters

Glucose transporters in brain in health and disease

Glucose transporters in the small intestine in health and disease

A Glimpse of Membrane Transport Through Structures—Advances in the Structural Biology of the GLUT Glucose Transporters

Mechanistic Study of Human Glucose Transport Mediated by GLUT1

A new perspective on the regulation of glucose and cholesterol transport by mitochondria-lysosome contact sites

Role of Rab proteins in glucose transporter 4 translocation:research advances

GLUT1: a Promising Drug Target for Cancer Treatment

A transporter on the move

Bridging the gap: glucose transporters, Alzheimer's, and future therapeutic prospects

The SLC transporter in nutrient and metabolic sensing, regulation, and drug development

Molecular mechanisms of the major facilitator superfamily transporters